“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.  
 

Technologist Robert Harrison and his attorneys filed the complaint in 2021, charging that shareholders grossly overpaid in the deal, among other contentions

Healthcare CFOs spend more time dealing with cost management and, by extension, operational issues than any other single set of items on their to-do lists.

The FDA has issued a Class I recall for Vyaire Medical respiratory support devices, saying use of older, defective devices could result in injury or death.

While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the business side of things. 

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.

“Applause broke out in the OR. It was quite an amazing experience,” recalls Winfred Williams, MD, associate professor of medicine at MGH and Slayman’s nephrologist, referring to the moment the kidney “immediately pinked up” during implantation. 

Making the hypothetical adjustment of switching all idle systems to off overnight and on weekends would save one hospital about $38,000. 
 

“Surprisingly,” experts wrote in Nature Medicine, experience-based factors such as a physicians’ subspecialty or previous AI use failed to reliably predict the technology's impact. 

Private payers eventually overturned more than half of denials, with the claims paid, but only after “multiple, costly rounds of provider appeals.”